ProjectHER-MES
Basic data
Title:
HER-MES
Duration:
16/04/2019 to 04/06/2020
Abstract / short description:
Randomized, double-blind, multicenter Head-to-head study of Erenumab against topiRamate - Migraine Study to assess tolerability and efficacy in a patiEnt-centered Setting (HER-MES).
Involved staff
Managers
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Contact persons
Faculty of Medicine
University of Tübingen
University of Tübingen
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Department of Neurology and Epileptology
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Funders
Nürnberg, Bayern, Germany